E
SenesTech, Inc. SNES
$1.26 -$0.02-1.56% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

SenesTech, Inc. is a U.S.-based biotechnology company focused on fertility control solutions for rodent pest management. The company operates primarily in the pest control, agricultural biotechnology, and public health sectors, developing products designed to reduce rodent populations through reproductive inhibition rather than conventional lethal control methods. Its principal revenue drivers are fertility-control products marketed to municipal agencies, commercial pest management providers, agricultural operators, and residential consumers. The company’s flagship products include ContraPest for rats and Evolve Mouse, which targets house mice populations.

The company positions itself as an alternative to traditional rodenticides amid increasing regulatory scrutiny of chemical poisons and growing concerns regarding environmental safety, secondary wildlife poisoning, and rodenticide resistance. SenesTech was founded in 2004 and evolved from a research-oriented biotechnology enterprise into a commercial-stage pest management company following regulatory approvals from the U.S. Environmental Protection Agency (EPA). Its strategy has increasingly emphasized integrated pest management solutions and broader commercialization through distribution partnerships and direct-to-market expansion.

Business Operations

SenesTech generates revenue primarily through sales of its fertility-control products and related pest management solutions. The company’s core operations are centered around its Fertility Control Technology platform, which uses active ingredients designed to reduce reproductive capacity in rodents over time. Commercial activities include manufacturing oversight, product distribution, regulatory compliance, and partnerships with pest control operators and agricultural distributors. The company’s business model combines direct sales with channel partnerships aimed at municipalities, food production facilities, warehouses, transit systems, and consumer retail markets.

Operations are concentrated in the United States, although the company has pursued international distribution and regulatory opportunities in select foreign markets. SenesTech relies on intellectual property protections, EPA registrations, scientific research capabilities, and proprietary formulations as strategic assets. The company has also entered partnerships with pest management distributors and commercial operators to broaden market penetration. Public filings and company disclosures identify continued investment in expanding product applications and improving distribution scale, though some details regarding the long-term commercial contribution of specific partnerships remain limited in publicly available sources.

Strategic Position & Investments

SenesTech’s strategic direction centers on expanding adoption of non-lethal rodent control technologies in response to tightening environmental regulations and increasing demand for sustainable pest management. Growth initiatives have included scaling commercialization of ContraPest, launching Evolve Mouse, increasing penetration into municipal and commercial accounts, and expanding e-commerce and retail distribution channels. The company has emphasized integrated pest management compatibility as a differentiator, positioning its products alongside traditional trapping and exclusion methods rather than solely as stand-alone replacements.

The company has invested in product development, regulatory approvals, manufacturing scalability, and marketing partnerships aimed at accelerating customer adoption. Strategic emphasis has also included targeting industries with high rodent-related compliance risks, such as food processing, agriculture, and urban infrastructure. Public disclosures indicate ongoing efforts to strengthen recurring revenue streams through broader distributor relationships and market education initiatives. Data regarding large-scale acquisitions or extensive subsidiary portfolios is inconclusive based on available public sources.

Geographic Footprint

SenesTech is headquartered in Arizona, United States, and its principal commercial activities are concentrated across the United States. The company markets products to municipalities, commercial pest management firms, agricultural customers, and residential users in multiple U.S. regions. Its operational focus has been strongest in urban and industrial environments where rodent control regulations and public health concerns are prominent.

The company has also explored international market opportunities through regulatory discussions and distribution arrangements in select foreign jurisdictions. Public disclosures reference interest in expansion opportunities in parts of North America, Asia-Pacific, and other international markets where rodent infestations materially affect agriculture and infrastructure. However, publicly available information indicates that international operations remain substantially smaller than domestic activities.

Leadership & Governance

SenesTech’s leadership team combines biotechnology, pest management, commercial operations, and public company experience. The company’s governance structure follows standard U.S. public-company practices, with executive leadership overseeing commercialization, regulatory strategy, scientific development, and financial operations. Management communications have consistently emphasized sustainable pest management, regulatory alignment, and long-term adoption of fertility control technologies as alternatives or complements to conventional rodenticides.

Key executives and leadership figures include:

  • Joel Fruendt – Chief Executive Officer
  • Tom Chesterman – Chief Financial Officer
  • Lori Corrigan – Executive Vice President of Research and Development
  • Ken Siegel – Executive Vice President of Sales and Marketing

The company’s strategic vision has focused on establishing fertility control as a mainstream category within integrated pest management while leveraging scientific validation, regulatory approvals, and environmental positioning to differentiate its offerings in the broader pest control industry.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $216.81
B
AAPL NASDAQ $311.32
B
AVGO NASDAQ $369.25
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $102.73
Top Financial Stocks
See All »
B
B
JPM NYSE $352.48
B
V NYSE $370.72
Top Health Care Stocks
See All »
B
LLY NYSE $1,263.36
B
JNJ NYSE $271.52
B
ABBV NYSE $265.62
Top Real Estate Stocks
See All »
B
PLD NYSE $140.64
B
EQIX NASDAQ $1,064.25